Top

EBMT 2025 CAR-T Data Collection Initiative Poster

… EBMT 2025 CAR-T Data Collection Initiative Poster …

My paper of the month - Consequences of increasing waiting times for treatment with commercially available autologous CAR-T cells targeting CD19 on the one-year all cause- survival for patients with relapsed/ refractory diffuse large B cell lymphoma.

… times on overall mortality of chimeric antigen receptor T-Cell Therapy in large B-Cell lymphoma: a discrete event … times for treatment with commercially available autologous CAR-T cells targeting CD19 on the one-year all cause- … engineered to express a Chimeric Antigen Receptor (CAR) or CAR-T Cells represent a promising therapy for …

EBMT 2022 CAR-T Data Collection Initiative-Post Authorisation Studies Poster

… EBMT 2022 CAR-T Data Collection Initiative-Post Authorisation Studies Poster …

EBMT 2023 CAR-T Data Collection Initiative - Post Authorisation Studies Poster

… EBMT 2023 CAR-T Data Collection Initiative - Post Authorisation Studies …

Complications post CAR-T Cell Therapy in Paediatric and Adult Patients

… Complications post CAR-T Cell Therapy in Paediatric and Adult Patients …

Nutritional Care Practices during CAR-T Cell Treatment in Adult Patients

… Nutritional Care Practices during CAR-T Cell Treatment in Adult Patients …

IDWP-CTIWP: Survey on vaccination strategy in CAR-T patients

… In most centres, vaccination strategies in CAR-T cell therapy are adopted from HCT vaccination protocols, while vaccine studies focused on the CAR-T population are limited. Collecting real-life data from …

Complications post CAR-T Cell Therapy in Paediatric and Adult Patients - Scientific Programme

… Complications post CAR-T Cell Therapy in Paediatric and Adult Patients - Scientific …

National Access and need for CAR-T CD19 therapy in Euro region

… National Access and need for CAR-T CD19 therapy in Euro region …

Survey on fertility procedures and outcomes for patients treated with CAR-T cell therapy

… procedures and outcomes for patients treated with CAR-T cell therapy …